Abstract:Background: Susceptibility to SARS-CoV-2 infection and severity of COVID-19 have high heterogeneity, but the underlying factors for such heterogeneity were largely unknown.Method: Based on the summary statistics from GWAS analyses for immune phenotypes and COVID-19 outcomes, comprehensive analyses (e.g., genetic correlation analysis for detection of the shared genetic components and Mendelian randomization (MR) analyses for causal association inference) were performed to elucidate the associations between 731 immune phenotypes and four COVID-19 outcome pairs.Results: The genetic correlations between COVID-19 outcomes and immune phenotypes were commonly observed, and 60 immune phenotypes were significantly correlated with four COVID-19 outcomes (64 pairs) (FDR < 0.05), among which the COVID-19 severity has the maximum number of significant pairs. Treg T cell panel and B cell panel have relatively more significant pairs in number. Pairwise gene-based analyses identified numerous pleiotropic genes for significant pairs identified. The gene set enrichment analysis revealed the involvement of the identified pleiotropic genes in complex immune processes (e.g., T-cell activation, innate immunity evasion, and cell-specific immune response). We observed significant causal effects of six immune phenotypes from 4 trait panels on any one of the two COVID-19 outcomes (i.e., COVID-19 severity and COVID-19 hospitalization) (FDR < 0.05), and of which CD19 on naïve-mature B cell was the only significant immune phenotype shared by the two COVID-19 outcomes.Conclusion: The more often observed significant correlations showed that the immune responses contribute to COVID-19 outcomes in a very complex pattern, and the differences in immune response among individuals are critical factors for the susceptibility to SARS-CoV-2 infection and severity of COVID-19. The findings greatly improved our understanding of the interaction between immune response and COVID-19 outcome, and also contribute to the detection of susceptible individuals and the design of therapeutic strategies from the perspectives of immunology.Funding Information: The study was supported by the Natural Science Foundation of China 30 (81872681 82173529, 82173598 and 82103922), the Science and Technology Project 31 of Suzhou (SS202050, SYS2019024), the QingLan Research Project of Jiangsu 32 Province, a Project of the Priority Academic Program Development of Jiangsu Higher 33 Education Institutions, and Postgraduate Research & Practice Innovation Program of 34 Jiangsu Province (KYCX22_3227).Declaration of Interests: Xing-Hao Yu, Rong-Rong Cao, Yi-Qun Yang, Han-Wen Cao, Shu-Feng Lei, and Fei-Yan Deng declare that they have no conflicts of interest.

Comparisons of the Immunological Landscape Between COVID-19, Influenza, and Respiratory Syncytial Virus Patients by Clustering Analysis.

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19)

Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19

Analysis of the Dynamic Relationship Between Immune Profiles and the Clinical Features of Patients with COVID-19

Analysis of Blood Index Characteristics in COVID-19 Patients and Their Associations with Different Outcomes

Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients

Single-cell landscape of immunological responses in patients with COVID-19

Risk Stratification of Hospitalized COVID-19 Patients Through Comparative Studies of Laboratory Results with Influenza

Distinct peripheral inflammatory profiles distinguish COVID-19 from influenza infection, with limited contributions from cytokine storm

Single-cell landscape of immunological responses in COVID-19 patients

Dynamic Differences of Immunological Parameters Between Severe and Non-severe COVID-19 Patients.

Comparison of Clinical Features and Outcomes of Medically Attended COVID-19 and Influenza Patients in a Defined Population in the 2020 Respiratory Virus Season

Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2

Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients

The Crucial Role of Immune Factors in Susceptibility to SARS-CoV-2 Infection and Severity of COVID-19

A systematic meta-analysis of immune signatures in patients with COVID-19

The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes

The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients

Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia

Comparisons of the Immunological Landscape of COVID-19 Patients Based on Sex and Disease Severity by Multi-Omics Analysis.